Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients

  • Matthew T. Harting
  • Kevin P. Lally
  • Richard J. Andrassy
  • Ara A. Vaporciyan
  • Charles S. CoxJr.
  • Andrea Hayes-Jordan
  • Martin L. Blakely
Original Paper

Abstract

Background

It is unclear whether age at diagnosis is an important prognostic factor in patients with osteosarcoma. Understanding this relationship could yield valuable insight into therapeutic rationale, focus patient selection for clinical trials, advance molecular concepts and theories, and expand current principles guiding prognosis. Our aim was to understand if age at diagnosis is a prognostic indicator for eventual outcome, as measured by disease-free survival and overall survival in patients with osteosarcoma.

Methods

Our cohort consisted of 438 patients of all ages who were diagnosed with osteosarcoma between 1 January 1980 and 31 December 2000 and who underwent the majority of their treatment at M.D. Anderson Cancer Center (MDACC). Patient and tumor specific variables were collected including patient demographics, patient history, primary tumor information (i.e., location, size, histology, extension, necrosis, etc.), treatment strategy (i.e., surgery, chemotherapy, and/or radiotherapy), metastatic disease information, long-term follow-up, and eventual outcome. Statistical analyses, including univariate and multivariate analyses were performed, with overall survival and disease-free survival as the primary outcome measures.

Results

The median age at diagnosis was 18.1 years (range 2 months to 78.8 years). Median follow-up was 4.2 years (range 5 days to 22.8 years) for all patients and 12.3 years (range 1 month to 22.8 years) for 209 surviving patients. Survival rates at 5, 10, and 15 years were 54.1, 47.2, and 45.2%, respectively. On univariate analyses, age ≥ 40 was found to be a poor prognostic factor. Other prognostic factors included tumor size, metastasis at diagnosis, soft-tissue tumor extension, surgery type, chemotherapy group, and tumor necrosis. Age was not identified a statistically significant prognostic variable on multivariate analysis.

Conclusions

Age at diagnosis does not appear to be a significant independent prognostic variable for overall survival or disease-free survival in patients with osteosarcoma. Although our data indicate that patients in the fifth decade and older fare worse than younger patients, other variables such as tumor necrosis, tumor extension, and tumor location are likely responsible for the observed decline in overall survival and disease-free survival.

Keywords

Osteosarcoma Prognosis Age 

Notes

Acknowledgments

We thank Barbara Whitehead and the medical records department for their efforts in data gathering. We are grateful to Lei Lei, and Robert Lasky for their assistance with the statistical analysis. We also appreciate critical appraisal from Virginia Moyer.

Conflict of interest statement

We declare that we have no conflict of interest.

References

  1. Alessandri AJ, Goddard KJ, Blair GK et al (2000) Age is the major determinant of recurrence in pediatric differentiated thyroid carcinoma. Med Pediatr Oncol 35:41–46CrossRefPubMedGoogle Scholar
  2. Bentzen SM, Poulsen HS, Kaae S et al (1988) Prognostic factors in osteosarcomas. A regression analysis. Cancer 62:194–202CrossRefPubMedGoogle Scholar
  3. Bielack SS, Kempf-Bielack B, Delling G et al (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20:776–790CrossRefPubMedGoogle Scholar
  4. Ferrari S, Bertoni F, Mercuri M et al (2001) Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute. Ann Oncol 12:1145–1150CrossRefPubMedGoogle Scholar
  5. French Bone Tumor Study Group (1988) Age and dose of chemotherapy as major prognostic factors in a trial of adjuvant therapy of osteosarcoma combining two alternating drug combinations and early prophylactic lung irradiation. Cancer 61:1304–1311CrossRefGoogle Scholar
  6. Glasser DB, Lane JM, Huvos AG et al (1992) Survival, prognosis, and therapeutic response in osteogenic sarcoma. The Memorial Hospital experience. Cancer 69:698–708CrossRefPubMedGoogle Scholar
  7. Grimer RJ, Cannon SR, Taminiau AM et al (2003) Osteosarcoma over the age of forty. Eur J Cancer 39:157–163CrossRefPubMedGoogle Scholar
  8. Hudson M, Jaffe MR, Jaffe N et al (1990) Pediatric osteosarcoma: therapeutic strategies, results, and prognostic factors derived from a 10-year experience. J Clin Oncol 8:1988–1997PubMedGoogle Scholar
  9. Joshi D, Anderson JR, Paidas C et al (2004) Age is an independent prognostic factor in Rhabdomyosarcoma: a report from the soft tissue sarcoma committee on the children’s oncology group. Pediatr Blood Cancer 42:64–73CrossRefPubMedGoogle Scholar
  10. Kager L, Zoubek A, Potschger U et al (2003) Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 21:2011–2018CrossRefPubMedGoogle Scholar
  11. Lockshin MD, Higgins IT (1968) Prognosis in osteogenic sarcoma. Clin Orthop 58:85–101PubMedGoogle Scholar
  12. Meyers PA, Heller G, Healey J et al (1992) Chemotherapy for non-metastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol 10:5–15PubMedGoogle Scholar
  13. Moriguchi S, Maehara Y, Korenaga D et al (1993) Relationship between age and the time of surgery and prognosis after gastrectomy for gastric cancer. J Surg Oncol 52:119–123CrossRefPubMedGoogle Scholar
  14. Nixon AJ, Neuberg D, Hayes DF et al (1994) Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 12:888–894PubMedGoogle Scholar
  15. Paksoy M, Ipek T, Colak T et al (1999) Influence of age on prognosis and management of patients with colorectal carcinoma. Eur J Surg 165:55–59CrossRefPubMedGoogle Scholar
  16. Petrilli AS, Gentil FC, Epelman S et al (1991) Increased survival, limb preservation, and prognostic factors for osteosarcoma. Cancer 68:733–737CrossRefPubMedGoogle Scholar
  17. Raymond AK, Chawla SP, Carrasco CH (1987) Osteosarcoma chemotherapy effect: a prognostic factor. Semin Diagn Pathol 4:212–236PubMedGoogle Scholar
  18. Rytting M, Pearson P, Raymond KA et al (2000) Osteosarcoma in preadolescent patients. Clin Orthop 373:39–50CrossRefPubMedGoogle Scholar
  19. Scranton PE, DeCicco FA, Totten RS et al (1975) Prognostic factors in osteosarcoma. A review of 20 years’ experience at the University of Pittsburg Health Center Hospitals. Cancer 36:2179–2191PubMedGoogle Scholar
  20. Spanier SS, Shuster JJ, VanderGriend RA (1990) The effect of local extent of the tumor on prognosis in osteosarcoma. J Bone Joint Surg 72:643–654PubMedGoogle Scholar
  21. Winkler K, Beron G, Kotz R et al (1984) Neoadjuvant chemotherapy for osteogenic sarcoma: results of a cooperative German/Austrian study. J Clin Oncol 2:617–624PubMedGoogle Scholar
  22. Xiong Q, Valero V, Kau V et al (2001) Female patients with breast carcinoma age 30 years and younger have a poor prognosis. The M.D. Anderson Cancer Center experience. Cancer 92:2523–2528CrossRefPubMedGoogle Scholar
  23. Yusim I, Mermershtain W, Neulander E et al (2002) Influence of age on the prognosis of patients with renal cell carcinoma (RCC). Onkologie 25:548–550CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Matthew T. Harting
    • 1
  • Kevin P. Lally
    • 2
    • 3
  • Richard J. Andrassy
    • 2
    • 3
  • Ara A. Vaporciyan
    • 4
  • Charles S. CoxJr.
    • 2
    • 3
  • Andrea Hayes-Jordan
    • 2
    • 3
  • Martin L. Blakely
    • 5
  1. 1.Department of SurgeryUniversity of MichiganAnn ArborUSA
  2. 2.Departments of Surgery and Pediatric SurgeryUniversity of Texas Medical SchoolHoustonUSA
  3. 3.Division of Surgical Oncology and PediatricsMD Anderson Cancer CenterHoustonUSA
  4. 4.Division of Thoracic Surgery, Department of SurgeryMD Anderson Cancer CenterHoustonUSA
  5. 5.Division of Pediatric Surgery, Department of SurgeryUniversity of Tennessee Health Science CenterMemphisUSA

Personalised recommendations